Animal Model Market Size (2024 - 2029)

The animal model market is anticipated to experience significant growth, driven by the increasing demand for these models in virology, infectious diseases, and drug testing studies. The adoption of CRISPR technology and the rise in R&D activities are key factors contributing to the expansion of the market size. The need for animal models is further propelled by their crucial role in vaccine development and understanding disease mechanisms, particularly in the context of emerging infectious diseases. Despite potential challenges posed by ethical regulations, the market is expected to continue its upward trajectory due to the ongoing advancements in genetic research and preclinical studies.

Market Size of Animal Model Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
 Animal Model Market Summary
Study Period 2021 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
CAGR 8.60 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

 Animal Model Market Major Players

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Animal Model Market Analysis

The animal model market is expected to register a CAGR of 8.6% over the forecast period.

The COVID-19 pandemic posed several challenges for the animal model market. For instance, an article published by NCBI, in July 2022, reported that, since the COVID-19 outbreak, animal models played a crucial role in aiding the rapid development of vaccines/drugs for the prevention and treatment of COVID-19, as well as understanding the pathogenesis of SARS-CoV-2 infection and immune responses of hosts, which led to increasing demand for animal models. However, due to the emergence of new SARS-CoV-2 strains and other new diseases, along with the continuous development of new drug molecules, the demand for animal models may continue to increase over the forecast period.

The rising usage of animal models in virology and infectious diseases, increased adoption of CRISPR technology, and an increasing number of R&D activities are driving the market's growth. The increasing number of infectious diseases leading to the death of billions of people worldwide have accelerated the development of vaccines, further increasing the use of animal models for drug testing studies. For instance, in February 2022, the WHO reported that 47,689 preclinical trial studies were registered in 2021. Thus, the increasing number of preclinical studies is also boosting the demand for animal models to conduct research, thereby driving the growth of the market.

The CRISPR-Cas system is used for target identification and validation, faster generation of safety models, and the development of cell-based therapies such as CAR-T cells for immunotherapy and CCR5 knockout cells for HIV treatment. Thus, the demand for animal models for production and quality control is increasing, thereby driving the market. For instance, an article published in the Molecular Neurobiology journal, in February 2022, reported that CRISPR/Cas9-based genome editing is becoming one of the most promising tools for treating human genetic diseases, including cardiovascular diseases, neuro-disorders, cancers, leading to the rising demand for animal genetic models for studying and treating human genetic disorders, particularly diseases associated with point mutations.

The development of CRISPR/Cas-9 technology is fueling the growth of the market. For instance, in September 2021, researchers from the Washington University School of Medicine used a mouse model to study the behavior of CRISPR-engineered cells for the treatment of rheumatoid arthritis. Hence, the increasing R&D in animal studies may further boost the growth of animal model market in the future.

However, regulations for the ethical use of animals may slow down the growth of the market over the forecast period.

Animal Model Industry Segmentation

As per the scope of the report, the animal model is a non-human species used in biomedical research because it can mimic aspects of a biological process or disease found in humans. Animal models such as mice, rats, zebrafish, and other animal types are sufficiently like humans in their anatomy, physiology, or response to a pathogen that researchers can extrapolate the results of animal model studies to better understand human physiology and disease. By using animal models, researchers can perform experiments that would be impractical or ethically prohibited with humans.

The animal model market is segmented by animal type (mice, birds, fish, cattle, and other animal types), technology (CRISPR, embryonic stem cell injection, nuclear transfer, and other technology), application (oncology, cardiovascular, neurology, and other applications) and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America).
The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Animal Type
Mice
Birds
Fish
Cattles
Other Animal Types
By Technology
CRISPR
Embryonic Stem Cell Injection
Nuclear Transfer
Other Technology
By Applications
Oncology
Cardiovascular
Neurology
Other Applications
By Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Animal Model Market Size Summary

The animal model market is poised for substantial growth, driven by the increasing application of these models in virology, infectious diseases, and the adoption of advanced technologies like CRISPR. The demand for animal models has surged, particularly due to their critical role in vaccine and drug development during the COVID-19 pandemic. This trend is expected to continue as new diseases and drug molecules emerge, necessitating further research and development. The market is also benefiting from the rising number of preclinical studies and the use of animal models in developing and validating therapies for various human genetic disorders. However, ethical regulations concerning the use of animals may pose challenges to market expansion.

The mice model segment is anticipated to experience significant growth, fueled by increased R&D activities in the pharmaceutical industry and the successful application of these models in various studies, including oncology and infectious disease research. North America is expected to witness notable growth due to its robust biomedical research infrastructure and significant investments in clinical trials. The region's market growth is further supported by technological advancements like CRISPR-Cas9, which enhance the capabilities of animal models. The market remains competitive and fragmented, with key players actively engaging in strategic alliances and collaborations to strengthen their positions and drive innovation.

Explore More

Animal Model Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rising Use of Animal Models in Virology and Infectious Diseases

      2. 1.2.2 Increased Adoption of CRISPR Technology

      3. 1.2.3 Increasing Number of R&D Activities

    3. 1.3 Market Restraints

      1. 1.3.1 Regulation for Ethical Use of Animals

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Animal Type

      1. 2.1.1 Mice

      2. 2.1.2 Birds

      3. 2.1.3 Fish

      4. 2.1.4 Cattles

      5. 2.1.5 Other Animal Types

    2. 2.2 By Technology

      1. 2.2.1 CRISPR

      2. 2.2.2 Embryonic Stem Cell Injection

      3. 2.2.3 Nuclear Transfer

      4. 2.2.4 Other Technology

    3. 2.3 By Applications

      1. 2.3.1 Oncology

      2. 2.3.2 Cardiovascular

      3. 2.3.3 Neurology

      4. 2.3.4 Other Applications

    4. 2.4 By Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Animal Model Market Size FAQs

The Animal Model Market is projected to register a CAGR of 8.60% during the forecast period (2024-2029)

Genoway, Labcorp UK Limited (Envigo Rms Inc.), Janvier Labs, Biocytogen Pharmaceuticals Co., Ltd. and Harbour BioMed Co. are the major companies operating in the Animal Model Market.

Animal Model Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)